Vitamin e
Berocca Pn, M.v.c. 9+, M.v.i, M.v.i. Lyophilized, Mvc, Vitaped (vitamin e) is an unknown pharmaceutical. Vitamin e was first approved as M.v.i.-12 lyophilized on 1985-08-08. It is used to treat alzheimer disease, drug-induced dyskinesia, hemolytic anemia, and vitamin e deficiency in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Phytonadione
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine
+
Riboflavin 5'-phosphate sodium
+
Thiamine
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
+
Vitamin k
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a palmitate
+
Vitamin e
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| a and d plus e | C200263 | 2024-08-08 |
| acne c-patch | unapproved drug other | 2018-02-10 |
| altra hand sanitizer with aloe and vitamin e | C200263 | 2024-07-23 |
| antiphlamine | unapproved drug other | 2017-05-11 |
| anyi beauty vitamin c evens skin tone face serum | C200263 | 2024-04-29 |
| astonea | C200263 | 2024-06-25 |
| batana hair oil | C200263 | 2024-06-24 |
| batana oil hair care cream | C200263 | 2024-05-17 |
| biotn | C200263 | 2024-07-09 |
| body milk for stretch marks | C200263 | 2024-07-31 |
Show 56 more
Indications
FDA
EMA
Show 23 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
1334 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 13 | 7 | 4 | 4 | 6 | 30 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 1 | 1 | — | 8 | 18 | 27 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | 1 | — | 8 | 17 | 26 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 1 | 8 | 4 | 5 | 9 | 25 |
| Colorectal neoplasms | D015179 | — | — | 8 | 7 | 3 | 1 | 4 | 21 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 3 | 2 | 4 | 5 | 6 | 19 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 4 | 3 | 3 | 2 | 8 | 18 |
| Oxidative stress | D018384 | EFO_1001905 | — | — | 3 | 1 | 1 | 12 | 17 |
| Covid-19 | D000086382 | — | U07.1 | — | 5 | 3 | 1 | 9 | 16 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 6 | 4 | 1 | 2 | 4 | 16 |
Show 99 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 70 | 4 | 2 | — | 23 | 98 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | 5 | 8 | — | 12 | 23 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 6 | 9 | 1 | — | 5 | 21 |
| Anemia | D000740 | HP_0001903 | D64.9 | 2 | 4 | 5 | — | 10 | 20 |
| Inflammation | D007249 | MP_0001845 | — | 1 | 2 | 1 | — | 15 | 18 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 4 | 6 | 1 | — | 7 | 18 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 3 | 2 | 9 | — | 1 | 15 |
| Prostatic neoplasms | D011471 | — | C61 | 4 | 4 | 4 | — | 2 | 14 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 5 | 2 | 4 | — | 2 | 13 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | 4 | 3 | — | 6 | 12 |
Show 139 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Asthma | D001249 | EFO_0000270 | J45 | 4 | 5 | — | — | 3 | 12 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 7 | 3 | — | — | 1 | 11 |
| Non-small-cell lung carcinoma | D002289 | — | — | 7 | 3 | — | — | — | 10 |
| Micronutrients | D018977 | — | — | — | 1 | — | — | 6 | 7 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 4 | 3 | — | — | — | 6 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 3 | — | — | 2 | 5 |
| Myelodysplastic syndromes | D009190 | — | D46 | 3 | 2 | — | — | — | 4 |
| Melanoma | D008545 | — | — | 4 | 1 | — | — | — | 4 |
| Hepatitis c | D006526 | — | B19.2 | 1 | 2 | — | — | 1 | 4 |
| Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | 1 | 1 | — | — | 3 | 4 |
Show 101 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 2 | — | — | — | 11 | 13 |
| Stroke | D020521 | EFO_0000712 | I63.9 | 2 | — | — | — | 5 | 7 |
| Iron deficiencies | D000090463 | — | E61.1 | 1 | — | — | — | 4 | 5 |
| Bacterial infections | D001424 | — | A49 | 2 | — | — | — | 2 | 4 |
| Macular edema | D008269 | — | — | 3 | — | — | — | 1 | 4 |
| Fatigue | D005221 | HP_0012378 | R53.83 | 1 | — | — | — | 3 | 4 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | — | — | — | — | 3 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 3 | — | — | — | — | 3 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | 3 | — | — | — | — | 3 |
| Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | 3 | — | — | — | — | 3 |
Show 54 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alopecia | D000505 | HP_0002293 | L64 | — | — | — | — | 6 | 6 |
| Arthralgia | D018771 | HP_0002829 | M25.5 | — | — | — | — | 5 | 5 |
| Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | — | — | 5 | 5 |
| Arthritis | D001168 | HP_0001369 | M05-M14 | — | — | — | — | 4 | 4 |
| Skin aging | D015595 | EFO_0005422 | — | — | — | — | — | 4 | 4 |
| Musculoskeletal diseases | D009140 | — | — | — | — | — | — | 4 | 4 |
| Knee prosthesis | D007720 | — | — | — | — | — | — | 4 | 4 |
| Dietary supplements | D019587 | — | — | — | — | — | — | 4 | 4 |
| Avitaminosis | D001361 | EFO_0005878 | E56.9 | — | — | — | — | 3 | 3 |
| Rhinitis | D012220 | EFO_0008521 | J31 | — | — | — | — | 3 | 3 |
Show 194 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Vitamin e |
| INN | phytomenadione |
| Description | (R,R,R)-alpha-tocopherol is an alpha-tocopherol that has R,R,R configuration. The naturally occurring stereoisomer of alpha-tocopherol, it is found particularly in sunflower and olive oils. It has a role as an antioxidant, a nutraceutical, an antiatherogenic agent, an EC 2.7.11.13 (protein kinase C) inhibitor, an anticoagulant, an immunomodulator, an antiviral agent, a micronutrient, an algal metabolite and a plant metabolite. It is an enantiomer of a (S,S,S)-alpha-tocopherol. |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 10191-41-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3989727 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | A034SE7857 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,907,326 documents
View more details
Safety
Black-box Warning
Black-box warning for: Nestabs one
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,516 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use